Skip to main content
Log in

Serum tissue polypeptide antigen (TPA) in thyroid cancer

  • Short Communication
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Serum tissue polypeptide antigen, (TPA), carcinoembryonic antigen (CEA), calcitonin (CT) and thyroglobulin (Tg) have been measured by specific radioimmunoassays in 174 patients with various types of thyroid cancer previously submitted to thyroidectomy. Elevated serum TPA concentrations were found in 12 of 13 patients with local invasion or distant metastases from undifferentiated thyroid cancer or thyroid lymphosarcoma, while serum Tg and CEA values were normal or undetectable. In 123 patients with well differentiated thyroid cancer serum TPA was usually normal regardless of the presence or absence of functioning metastases. On the contrary, 14 of 15 patients with “dedifferentiated” metastases from previously differentiated thyroid cancer had elevated serum TPA values, while serum CEA was normal and serum Tg variable. Serum CT was confirmed as the most sensitive marker of metastatic medullary thyroid carcinoma, but elevated serum TPA values were also found in most of these cases. The present data indicate that serum TPA provides a new humoral marker in the follow-up of undifferentiated and “dedifferentiated” thyroid carcinoma and may also be usefully employed as an additional marker for medullary thyroid carcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Van Herle A., Vassart G., Dumont J.E. Control of thyroglobulin synthesis and secretion (second of two part). N. Engl. J. Med. 307: 307, 1979.

    Article  Google Scholar 

  2. Pacini F., Pinchera A., Giani C., Grasso L., Doveri F., Baschieri L. Serum thyroglobulin in thyroid carcinoma and other thyroid disorders. J. Endocrinol. Invest. 3: 283, 1980.

    Article  PubMed  CAS  Google Scholar 

  3. Hazard J.B. The C-cells(parafollicular cells) of the thyroid gland and medullary thyroid carcinoma. Am. J. Pathol. 88: 214, 1977.

    Google Scholar 

  4. Ishikawa N., Hamada S. Association of medullary carcinoma of the thyroid with carcinoembryonic antigen. Br. J. Cancer 34: 111, 1976.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  5. DeLellis R.A., Rule A.H., Spiler I., Nathanson L., Tashijian A.H. Jr., Wolfe H.J. Calcitonin and carcinoembryonic antigen as tumor markes in medullary thyroid carcinoma. Am. J. Clin. Pathol. 70: 587, 1978.

    PubMed  CAS  Google Scholar 

  6. Calmettes C., Moukhttar M.S., Milhaud G. Plasma carcinoembryonic antigen versus plasma calcitonin in the diagnosis of the medullary carcinoma of the thyroid. Cancer Immunol. Imunother. 4: 251, 1978.

    CAS  Google Scholar 

  7. Burtin P., Calmettes C., Fondaneche M.C. CEA and non-specific cross-reacting antigen (NCA) in medullary carcinoma of the thyroid.

  8. Beatty J.D., and Terz J.J. Value of carcinoembryonic antigen in clinical medicine. In: Ariel I.M. (Ed.), Progress in Clinical Cancer, vol. VIII, Gr-Stratton New York, 1982, p. 9.

    Google Scholar 

  9. Baschieri L., Giani C., Mariotti S., Pacini F., Busnardo B., Girelli M.E., Pinchera A. Markers of thyroid tumors. In: Colnaghi M.I., Buraggi G.L., Ghione M. (Eds.), Markers for diagnosis and monitoring of human cancer. Academy Press, New York, 1982, p. 259.

    Google Scholar 

  10. Pacini F., Pinchera A., Giani C., Grasso L., Baschieri L. Serum thyroglobulin concentration and 131-l whole body scan in the diagnosis of metastases from differentiated thyroid carcinoma (after thyroidectomy). Clin. Endocrinol. (Oxf.) 13: 207, 1980.

    Article  Google Scholar 

  11. Bjorklund B., Bjorklund V. Antigenicity of pooled human malignant and normal tissues by cyto-immunological technique: presence of an insoluble, hdeatlabile tumor antigen. Int. Arch. All. Appl. Immun. 10: 153, 1957.

    Article  CAS  Google Scholar 

  12. Bjorklund B., Bjorklund V. Specificity and basis of the tissue polypeptide antigen. Cancer Detect. Prevent. 6: 41, 1983.

    PubMed  CAS  Google Scholar 

  13. Lüthgens M., Schlegel G. Combined use of carcino-embryonic antigen and tissue polypeptide antigen in oncologic therapy and surveillance. Cancer Detect. Prevent. 6: 51, 1983.

    PubMed  Google Scholar 

  14. Wiklund B., Luning B. Bjorklund B. Chemical studies of tissue polypeptide antigen (TPA). III. On the nature of the antigenic determinant of TPA subfraction B1. Acta Chem. Scand. 35: 325, 1981.

    Article  CAS  Google Scholar 

  15. Bjorklund B. Tissue polipeptyde antigen (TPA): biology, biochemistry, improved assay metodology, clinical significance in cancer and other conditions and future outlook. Antib. Chemioter. 2: 16, 1978.

    Google Scholar 

  16. Menendez-Botet C.I., Oettgen H.F., Pinshy C.M., Schwartz M.K. A preliminary evaluation of tissue polypeptide antigen in serum or urine (or both) of patients with cancer of benign neoplasm. Clin. Chem. 24: 868, 1978.

    PubMed  CAS  Google Scholar 

  17. Mross K., Mross B., Wolfrum D.I., Rauschecker H. Determination of TPA in breast cancer and controls. Klin. Wochenschr. 61: 461, 1983.

    Article  PubMed  CAS  Google Scholar 

  18. Schlegel G., Luthgens M., Eklund G., Bjorklund B. Correlation between activity in brast cancer and CEA, TPA and eighteen common laboratory procedure and improvement by combined use of CEA and TPA. Tumor Diagnostik 2: 6, 1981.

    Google Scholar 

  19. Mariotti S., Cupini C., Giani C., Lari R., Rolleri E., Falcao A., Marchisio M., Pinchera A. Evaluation of a solid phase immunoradiometric assay (IRMA) for serum thyroglobulin: effect of antithyroglobul-in antibody. Clin. Chim. Acta 123: 347, 1982.

    Article  PubMed  CAS  Google Scholar 

  20. Luthgens M., Schlegel G.T. Verlaufskontrolle mit Tissue Polypeptide Antigen und Carcinoembryonalem Antigen in der Radiosonkologischen Nachsorge and Therapie. Tumor Diagnostik 2: 179, 1981.

    Google Scholar 

  21. Nemoto T., Constantine R., Chu T.M. Human tissue polypeptide antigen in brast cancer. J.N.C.I. 63: 1347, 1979.

    CAS  Google Scholar 

  22. Van Herle A.J., Uller R.P. Evaluated serum thyroglobulin: a marker of metastases in a differentiated thyroid carcinoma. J. Clin. Invest. 56: 272, 1975.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  23. Harada T., Ito K., Shimaoka K., Hosoda Y., Yakumaru K. Fatal thyroid carcinoma. Anaplastic transformation of a adenocarcinoma. Cancer 39: 2588, 1977.

    Article  PubMed  CAS  Google Scholar 

  24. Lundstrom R., Bjorklund B., Eklund G. A tissue derived polypeptide antigen: its relation to cancer and its temporary occurrence in certain infectious diseases. In: B. Bjorklund (Ed.), Immunological tecniques for detection of cancer Bonniers, Stockolm, 1973, p. 243.

    Google Scholar 

  25. Ruibal A., Clotet B., Pigrau G., Duran-Bellido P., Fraile M., Roca I. Tissue polyptide antigen in autoimmune disease. Tumor Diagnostik 3: 40, 1982.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This work has been supported in part by a grant from C.N.R. (Roma, Italy) Progetto Finalizzato Oncologia, Sottoprogetto 10.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Martino, E., Bambini, G., Aghini-Lombardi, F. et al. Serum tissue polypeptide antigen (TPA) in thyroid cancer. J Endocrinol Invest 7, 249–252 (1984). https://doi.org/10.1007/BF03348433

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03348433

Key-words

Navigation